scholarly journals Bayesian graphical models for modern biological applications

Author(s):  
Yang Ni ◽  
Veerabhadran Baladandayuthapani ◽  
Marina Vannucci ◽  
Francesco C. Stingo

AbstractGraphical models are powerful tools that are regularly used to investigate complex dependence structures in high-throughput biomedical datasets. They allow for holistic, systems-level view of the various biological processes, for intuitive and rigorous understanding and interpretations. In the context of large networks, Bayesian approaches are particularly suitable because it encourages sparsity of the graphs, incorporate prior information, and most importantly account for uncertainty in the graph structure. These features are particularly important in applications with limited sample size, including genomics and imaging studies. In this paper, we review several recently developed techniques for the analysis of large networks under non-standard settings, including but not limited to, multiple graphs for data observed from multiple related subgroups, graphical regression approaches used for the analysis of networks that change with covariates, and other complex sampling and structural settings. We also illustrate the practical utility of some of these methods using examples in cancer genomics and neuroimaging.


Author(s):  
Finn V. Jensen ◽  
Thomas D. Nielsen


Author(s):  
David Wooff ◽  
Michael Goldstein ◽  
Frank Coolen


Author(s):  
B.V.K. Vijaya Kumar ◽  
Vishnu Naresh Boddeti ◽  
Jonathon M. Smereka ◽  
Jason Thornton ◽  
Marios Savvides


Author(s):  
Wenting Wang ◽  
Veerabhadran Baladandayuthapani ◽  
Chris C. Holmes ◽  
Kim-Anh Do


1995 ◽  
Vol 63 (2) ◽  
pp. 215 ◽  
Author(s):  
David Madigan ◽  
Jeremy York ◽  
Denis Allard




2020 ◽  
Vol 38 (6_suppl) ◽  
pp. 570-570
Author(s):  
Sergiusz Wesolowski ◽  
Roberto Nussenzveig ◽  
Victor Sacristan Santos ◽  
John Esther ◽  
Divyam Goel ◽  
...  

570 Background: AI is increasingly being used in clinical cancer genomics research. Probabilistic Graphical Models (PGMs) are AI algorithms that capture multivariate, mutli-level dependencies in complex patterns in large datasets while retaining human interpretability. We hypothesize that PGMs can identify clinical and genomic features that correlate with IO response in patients (pts) with mUC. Methods: In this retrospective study eligibility criteria were: diagnosis of mUC, receipt of IO for mUC, comprehensive genomic profiling data available from CLIA certified labs. The Bayesian Network (BN, PGM based AI) was used to discover clinical characteristics and selected genomic alterations relevant to IO response by RECIST 1.1 (investigator assessed). Results: Overall, 95 pts (73 men) with mUC were evaluated. 45 (47%) were ever smokers.The presented BN correctly captured the clinical landscape of mUC explaining significant relationship between included variables (p<0.0001). Ever smokers and pts with de novo metastasis had higher TMB and better response to IO. Inactivating MLL2 alterations were more prevalent in non-smokers, and negatively correlated with response to IO. FGFR3 alterations did not predict response to IO. Significant associations are presented in Table. Conclusions: These hypothesis-generating data (by a novel approach, i.e. PGM based AI) showed that smoking and high-TMB were associated with improved response to IO; in contrast, inactivating MLL2 alternations and visceral metastasis predicted inferior response. FGFR3 alterations did not correlate with response. This model validated previous findings and found new hypothesis-generating relationship, such as altered MLL2 gene; external validation is needed.[Table: see text]



2000 ◽  
Vol 19 (16) ◽  
pp. 2147-2168 ◽  
Author(s):  
Heidi H. Hundborg ◽  
Malene Højbjerre ◽  
Ole Bjarne Christiansen ◽  
Steffen L. Lauritzen


Sign in / Sign up

Export Citation Format

Share Document